-
-
-
-
-
-
-
Carmila - First-half 2025 Results: Acceleration in Growth and Recurring Earnings Outlook Revised Upwards
-
-
-
-
-
-
-
Carmila: 2024 Annual Results: Sustained Growth Driven by the Acquisition of Galimmo and Strong Leasing Momentum
-
-
-
-
-
-
-
Carisma Therapeutics Announces Changes to its Board of Directors
-
-
-
-
-
-
-
Carmila: Financial Information as of 30 September 2023
-
-
-
-
-
-
-
MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary
-
-
-
-
-
-
-
Carmila: Launch of a Share Buyback Program for €10 Million
-
-
-
-
-
-
-
Carmila: Financial information at 30 September 2018
-
1,177,958 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

